40 women exploited in egg extraction racket, one underwent procedure 33 times

An illegal human egg extraction racket is an unauthorised scheme that recruits women, removes their eggs and arranges their commercial sale. It matters because the alleged operation involved repeated procedures, financial inducements and medical treatment without proper supervision.

In Badlapur, officials say women were recruited and offered Rs 25,000 to Rs 30,000. Ovulation-stimulating injections were allegedly stored and administered at Sulakshana Gadekar’s home. The women then underwent unauthorised sonography-guided procedures before doctors at collaborating IVF and medical centres extracted their eggs in operation theatres.

The Thane police uncovered the network in February and arrested three women, including Gadekar. The ED later searched locations in Badlapur. Investigators are examining agents, healthcare facilities and medical professionals, while assessing alleged violations of India’s Assisted Reproductive Technology (Regulation) Act, 2021.

The alleged racket was large enough to involve more than 40 women, according to investigators. It reportedly targeted economically distressed women by offering money for their eggs, turning financial need into a recruitment tool for medical procedures.

The promised payments ranged from Rs 25,000 to Rs 30,000 per woman. The most striking allegation concerns one donor who underwent egg extraction 33 times. Investigators say the procedures were connected to a network that gave women ovulation-stimulating injections and took them to collaborating medical facilities.

These figures have made the case a serious investigation into possible exploitation and unsafe medical practice. The article does not state how many procedures each other woman underwent. Authorities are also examining the agents, doctors and healthcare facilities allegedly involved in recruiting women and extracting eggs for commercial sale.

The article describes several alleged roles rather than naming every participant. The network and its agents recruited women, allegedly targeting those facing economic distress. Sulakshana Gadekar, described as the alleged local kingpin, reportedly ran the operation from her home.

Investigators say fertility-related, ovulation-stimulating injections were stored and administered there without proper medical supervision. Women then underwent unauthorised sonography-guided procedures and were taken to collaborating IVF and medical centres. Doctors at those facilities allegedly extracted the eggs in operation theatres for commercial sale.

Thane police uncovered the racket in February and arrested three women, including Gadekar. The Enforcement Directorate later conducted searches in Badlapur. The investigation is examining alleged links among recruiters, injection administrators, doctors, agents and healthcare facilities that may have facilitated the procedures.

In-vitro fertilisation, or IVF, is a fertility treatment in which an egg and sperm are combined in a laboratory. If an embryo develops, it may later be transferred to the uterus. Egg extraction is therefore a key step when eggs are needed for laboratory fertilisation or related assisted-reproduction procedures.

Typically, fertility medicines stimulate the ovaries to mature multiple eggs. Doctors then use a guided procedure to collect them. The article says the Badlapur network administered ovulation-stimulating injections and took women to collaborating IVF and medical centres, where doctors extracted eggs in operation theatres.

The case differs from a routine, properly regulated IVF procedure because authorities allege unauthorised procedures, commercial sale and inadequate medical supervision. The article does not identify the intended recipients of the eggs or describe any specific IVF treatment resulting from the extractions. Those details remain outside the reported facts.

Egg extraction is an invasive medical procedure, and fertility-stimulating medicines affect the ovaries. Known possible complications include ovarian hyperstimulation syndrome, pain, bleeding, infection and reactions to sedation. Rare but serious problems can include ovarian twisting or damage. Risk depends on the medicines, the person’s health and the quality of care.

Repeated retrievals may add procedural and medication-related risks, especially if recovery and monitoring are inadequate. The article reports that one donor allegedly underwent extraction 33 times. It also says injections were stored and administered at Gadekar’s home without proper medical supervision, followed by unauthorised sonography-guided procedures.

The article does not report specific injuries or medical outcomes among the women. However, the repeated procedures and alleged lack of supervision prompted serious health concerns. Proper assessment, monitoring and follow-up are important safeguards in fertility treatment; authorities are investigating whether those safeguards were absent here.

The Assisted Reproductive Technology (Regulation) Act, 2021 governs assisted reproductive technology procedures and human egg donation. According to the article, it permits a woman to donate eggs only once in her lifetime and prohibits financial gain from such donations.

Those rules address two central concerns in this case. A lifetime limit is meant to prevent repeated egg extraction from the same donor. The ban on financial gain is meant to keep donation from becoming a commercial transaction that could pressure financially vulnerable women. The article identifies both alleged payments and repeated procedures as key concerns.

Authorities suspect the Badlapur operation breached these provisions. Women were allegedly offered Rs 25,000 to Rs 30,000, while one donor allegedly underwent extraction 33 times. Investigators are examining recruiters, agents, medical professionals and facilities to establish how the procedures were arranged and whether the law was violated.

Economically distressed women may have fewer safe ways to earn money and may feel pressure to accept an offer that promises immediate payment. That pressure can make it harder to question medical claims, negotiate terms or refuse a risky procedure. Financial need does not mean a woman freely accepts every risk without influence.

The article says the Badlapur network targeted economically distressed women with offers of Rs 25,000 to Rs 30,000. It also alleges that fertility injections were administered without proper medical supervision and that women underwent unauthorised sonography-guided procedures before egg extraction at collaborating facilities.

The alleged combination of financial inducement and inadequate oversight is why the case raises exploitation concerns. Investigators are examining recruiters, agents, doctors and healthcare facilities. The article does not describe each woman’s personal circumstances, so it cannot establish how any individual decided to participate or understood the medical risks.